Loading…
Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan
Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross‐sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean ± SD age, 52 ± 17 years; age range, 16– 91 years) was conducted in Japan. The use of benzodiazepine‐...
Saved in:
| Published in: | Psychiatry and clinical neurosciences 2009-04, Vol.63 (2), p.244-246 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c4520-1ec0dd442174063d63ce10b1fe036f5324647c712ec5fcde852a9d64c38724753 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c4520-1ec0dd442174063d63ce10b1fe036f5324647c712ec5fcde852a9d64c38724753 |
| container_end_page | 246 |
| container_issue | 2 |
| container_start_page | 244 |
| container_title | Psychiatry and clinical neurosciences |
| container_volume | 63 |
| creator | Uchida, Hiroyuki Suzuki, Takefumi Mamo, David C. Mulsant, Benoit H. Tsunoda, Kenichi Takeuchi, Hiroyoshi Kikuchi, Toshiaki Nakajima, Shinichiro Nomura, Kensuke Tomita, Masayuki Watanabe, Koichiro Kashima, Haruo |
| description | Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross‐sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean ± SD age, 52 ± 17 years; age range, 16– 91 years) was conducted in Japan. The use of benzodiazepine‐derivative anxiolytics was approximately 60% in all decades, including older patients, without a group difference. The frequent use of benzodiazepines is a cause for concern because they are not preferred treatment, given their well‐known adverse effects especially in the elderly. |
| doi_str_mv | 10.1111/j.1440-1819.2008.01920.x |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67107552</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20546154</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4520-1ec0dd442174063d63ce10b1fe036f5324647c712ec5fcde852a9d64c38724753</originalsourceid><addsrcrecordid>eNqNkUtv1DAUhS0Eog_4C8gb2E3w9SNOFizQiEdRRSsBKxaWx74RHmXiYCe001-Pw4zaZbF05SPd79pX5xBCgVVQztttBVKyFTTQVpyxpmLQclbdPiGn942nRQsuViCgPiFnOW8ZY0LU8JycQAtaadWekp_f5vQH9zR2dIPDXfTB3uEYBqR28KWm4HFMmHORdM5Iw0DjPI12CjhMmd6E6RfdxeipDzkmjykvyBc72uEFedbZPuPL431Ofnz88H39eXV59eli_f5y5aTiZVl0zHspOWjJauFr4RDYBjpkou6U4LKW2mng6FTnPDaK29bX0olGc6mVOCdvDu-OKf6eMU9mF7LDvrcDxjmbWgPTSvFHQc6UrEHJAjYH0KWYc8LOjCnsbNobYGZJwGzNYrRZjDZLAuZfAua2jL46_jFvdugfBo-WF-D1EbDZ2b5LdnAh33MchGBtowv37sDdhB73_72AuV5_XZT4C7_2oUQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20546154</pqid></control><display><type>article</type><title>Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan</title><source>Wiley</source><creator>Uchida, Hiroyuki ; Suzuki, Takefumi ; Mamo, David C. ; Mulsant, Benoit H. ; Tsunoda, Kenichi ; Takeuchi, Hiroyoshi ; Kikuchi, Toshiaki ; Nakajima, Shinichiro ; Nomura, Kensuke ; Tomita, Masayuki ; Watanabe, Koichiro ; Kashima, Haruo</creator><creatorcontrib>Uchida, Hiroyuki ; Suzuki, Takefumi ; Mamo, David C. ; Mulsant, Benoit H. ; Tsunoda, Kenichi ; Takeuchi, Hiroyoshi ; Kikuchi, Toshiaki ; Nakajima, Shinichiro ; Nomura, Kensuke ; Tomita, Masayuki ; Watanabe, Koichiro ; Kashima, Haruo</creatorcontrib><description>Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross‐sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean ± SD age, 52 ± 17 years; age range, 16– 91 years) was conducted in Japan. The use of benzodiazepine‐derivative anxiolytics was approximately 60% in all decades, including older patients, without a group difference. The frequent use of benzodiazepines is a cause for concern because they are not preferred treatment, given their well‐known adverse effects especially in the elderly.</description><identifier>ISSN: 1323-1316</identifier><identifier>EISSN: 1440-1819</identifier><identifier>DOI: 10.1111/j.1440-1819.2008.01920.x</identifier><identifier>PMID: 19175759</identifier><language>eng</language><publisher>Melbourne, Australia: Blackwell Publishing Asia</publisher><subject>Adolescent ; Adult ; Age Factors ; Aged ; Aged, 80 and over ; aging ; Anti-Anxiety Agents - therapeutic use ; antidepressants ; Antidepressive Agents - therapeutic use ; benzodiazepine ; Benzodiazepines - therapeutic use ; Biological and medical sciences ; Cross-Sectional Studies ; Drug Utilization ; Female ; Health Care Surveys ; Humans ; Japan - epidemiology ; Male ; Medical sciences ; Middle Aged ; mood disorders ; Mood Disorders - drug therapy ; Mood Disorders - epidemiology ; Mood Disorders - psychology ; Neuropharmacology ; Outpatients ; Pharmacology. Drug treatments ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer ; Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) ; Psychology. Psychoanalysis. Psychiatry ; Psychopharmacology ; Young Adult</subject><ispartof>Psychiatry and clinical neurosciences, 2009-04, Vol.63 (2), p.244-246</ispartof><rights>2009 The Authors. Journal compilation © 2009 Japanese Society of Psychiatry and Neurology</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4520-1ec0dd442174063d63ce10b1fe036f5324647c712ec5fcde852a9d64c38724753</citedby><cites>FETCH-LOGICAL-c4520-1ec0dd442174063d63ce10b1fe036f5324647c712ec5fcde852a9d64c38724753</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21330987$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19175759$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Uchida, Hiroyuki</creatorcontrib><creatorcontrib>Suzuki, Takefumi</creatorcontrib><creatorcontrib>Mamo, David C.</creatorcontrib><creatorcontrib>Mulsant, Benoit H.</creatorcontrib><creatorcontrib>Tsunoda, Kenichi</creatorcontrib><creatorcontrib>Takeuchi, Hiroyoshi</creatorcontrib><creatorcontrib>Kikuchi, Toshiaki</creatorcontrib><creatorcontrib>Nakajima, Shinichiro</creatorcontrib><creatorcontrib>Nomura, Kensuke</creatorcontrib><creatorcontrib>Tomita, Masayuki</creatorcontrib><creatorcontrib>Watanabe, Koichiro</creatorcontrib><creatorcontrib>Kashima, Haruo</creatorcontrib><title>Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan</title><title>Psychiatry and clinical neurosciences</title><addtitle>Psychiatry Clin Neurosci</addtitle><description>Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross‐sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean ± SD age, 52 ± 17 years; age range, 16– 91 years) was conducted in Japan. The use of benzodiazepine‐derivative anxiolytics was approximately 60% in all decades, including older patients, without a group difference. The frequent use of benzodiazepines is a cause for concern because they are not preferred treatment, given their well‐known adverse effects especially in the elderly.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Age Factors</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>aging</subject><subject>Anti-Anxiety Agents - therapeutic use</subject><subject>antidepressants</subject><subject>Antidepressive Agents - therapeutic use</subject><subject>benzodiazepine</subject><subject>Benzodiazepines - therapeutic use</subject><subject>Biological and medical sciences</subject><subject>Cross-Sectional Studies</subject><subject>Drug Utilization</subject><subject>Female</subject><subject>Health Care Surveys</subject><subject>Humans</subject><subject>Japan - epidemiology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>mood disorders</subject><subject>Mood Disorders - drug therapy</subject><subject>Mood Disorders - epidemiology</subject><subject>Mood Disorders - psychology</subject><subject>Neuropharmacology</subject><subject>Outpatients</subject><subject>Pharmacology. Drug treatments</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</subject><subject>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</subject><subject>Psychology. Psychoanalysis. Psychiatry</subject><subject>Psychopharmacology</subject><subject>Young Adult</subject><issn>1323-1316</issn><issn>1440-1819</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><recordid>eNqNkUtv1DAUhS0Eog_4C8gb2E3w9SNOFizQiEdRRSsBKxaWx74RHmXiYCe001-Pw4zaZbF05SPd79pX5xBCgVVQztttBVKyFTTQVpyxpmLQclbdPiGn942nRQsuViCgPiFnOW8ZY0LU8JycQAtaadWekp_f5vQH9zR2dIPDXfTB3uEYBqR28KWm4HFMmHORdM5Iw0DjPI12CjhMmd6E6RfdxeipDzkmjykvyBc72uEFedbZPuPL431Ofnz88H39eXV59eli_f5y5aTiZVl0zHspOWjJauFr4RDYBjpkou6U4LKW2mng6FTnPDaK29bX0olGc6mVOCdvDu-OKf6eMU9mF7LDvrcDxjmbWgPTSvFHQc6UrEHJAjYH0KWYc8LOjCnsbNobYGZJwGzNYrRZjDZLAuZfAua2jL46_jFvdugfBo-WF-D1EbDZ2b5LdnAh33MchGBtowv37sDdhB73_72AuV5_XZT4C7_2oUQ</recordid><startdate>200904</startdate><enddate>200904</enddate><creator>Uchida, Hiroyuki</creator><creator>Suzuki, Takefumi</creator><creator>Mamo, David C.</creator><creator>Mulsant, Benoit H.</creator><creator>Tsunoda, Kenichi</creator><creator>Takeuchi, Hiroyoshi</creator><creator>Kikuchi, Toshiaki</creator><creator>Nakajima, Shinichiro</creator><creator>Nomura, Kensuke</creator><creator>Tomita, Masayuki</creator><creator>Watanabe, Koichiro</creator><creator>Kashima, Haruo</creator><general>Blackwell Publishing Asia</general><general>Wiley-Blackwell</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope></search><sort><creationdate>200904</creationdate><title>Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan</title><author>Uchida, Hiroyuki ; Suzuki, Takefumi ; Mamo, David C. ; Mulsant, Benoit H. ; Tsunoda, Kenichi ; Takeuchi, Hiroyoshi ; Kikuchi, Toshiaki ; Nakajima, Shinichiro ; Nomura, Kensuke ; Tomita, Masayuki ; Watanabe, Koichiro ; Kashima, Haruo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4520-1ec0dd442174063d63ce10b1fe036f5324647c712ec5fcde852a9d64c38724753</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Age Factors</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>aging</topic><topic>Anti-Anxiety Agents - therapeutic use</topic><topic>antidepressants</topic><topic>Antidepressive Agents - therapeutic use</topic><topic>benzodiazepine</topic><topic>Benzodiazepines - therapeutic use</topic><topic>Biological and medical sciences</topic><topic>Cross-Sectional Studies</topic><topic>Drug Utilization</topic><topic>Female</topic><topic>Health Care Surveys</topic><topic>Humans</topic><topic>Japan - epidemiology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>mood disorders</topic><topic>Mood Disorders - drug therapy</topic><topic>Mood Disorders - epidemiology</topic><topic>Mood Disorders - psychology</topic><topic>Neuropharmacology</topic><topic>Outpatients</topic><topic>Pharmacology. Drug treatments</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer</topic><topic>Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease)</topic><topic>Psychology. Psychoanalysis. Psychiatry</topic><topic>Psychopharmacology</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Uchida, Hiroyuki</creatorcontrib><creatorcontrib>Suzuki, Takefumi</creatorcontrib><creatorcontrib>Mamo, David C.</creatorcontrib><creatorcontrib>Mulsant, Benoit H.</creatorcontrib><creatorcontrib>Tsunoda, Kenichi</creatorcontrib><creatorcontrib>Takeuchi, Hiroyoshi</creatorcontrib><creatorcontrib>Kikuchi, Toshiaki</creatorcontrib><creatorcontrib>Nakajima, Shinichiro</creatorcontrib><creatorcontrib>Nomura, Kensuke</creatorcontrib><creatorcontrib>Tomita, Masayuki</creatorcontrib><creatorcontrib>Watanabe, Koichiro</creatorcontrib><creatorcontrib>Kashima, Haruo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Psychiatry and clinical neurosciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Uchida, Hiroyuki</au><au>Suzuki, Takefumi</au><au>Mamo, David C.</au><au>Mulsant, Benoit H.</au><au>Tsunoda, Kenichi</au><au>Takeuchi, Hiroyoshi</au><au>Kikuchi, Toshiaki</au><au>Nakajima, Shinichiro</au><au>Nomura, Kensuke</au><au>Tomita, Masayuki</au><au>Watanabe, Koichiro</au><au>Kashima, Haruo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan</atitle><jtitle>Psychiatry and clinical neurosciences</jtitle><addtitle>Psychiatry Clin Neurosci</addtitle><date>2009-04</date><risdate>2009</risdate><volume>63</volume><issue>2</issue><spage>244</spage><epage>246</epage><pages>244-246</pages><issn>1323-1316</issn><eissn>1440-1819</eissn><abstract>Data on benzodiazepine use in mood disorders are still limited, especially among seniors. A cross‐sectional review of psychotropic prescriptions in 948 outpatients with mood disorders (405 male; mean ± SD age, 52 ± 17 years; age range, 16– 91 years) was conducted in Japan. The use of benzodiazepine‐derivative anxiolytics was approximately 60% in all decades, including older patients, without a group difference. The frequent use of benzodiazepines is a cause for concern because they are not preferred treatment, given their well‐known adverse effects especially in the elderly.</abstract><cop>Melbourne, Australia</cop><pub>Blackwell Publishing Asia</pub><pmid>19175759</pmid><doi>10.1111/j.1440-1819.2008.01920.x</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1323-1316 |
| ispartof | Psychiatry and clinical neurosciences, 2009-04, Vol.63 (2), p.244-246 |
| issn | 1323-1316 1440-1819 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_67107552 |
| source | Wiley |
| subjects | Adolescent Adult Age Factors Aged Aged, 80 and over aging Anti-Anxiety Agents - therapeutic use antidepressants Antidepressive Agents - therapeutic use benzodiazepine Benzodiazepines - therapeutic use Biological and medical sciences Cross-Sectional Studies Drug Utilization Female Health Care Surveys Humans Japan - epidemiology Male Medical sciences Middle Aged mood disorders Mood Disorders - drug therapy Mood Disorders - epidemiology Mood Disorders - psychology Neuropharmacology Outpatients Pharmacology. Drug treatments Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer Psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (alzheimer disease) Psychology. Psychoanalysis. Psychiatry Psychopharmacology Young Adult |
| title | Survey of benzodiazepine and antidepressant use in outpatients with mood disorders in Japan |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T07%3A47%3A25IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Survey%20of%20benzodiazepine%20and%20antidepressant%20use%20in%20outpatients%20with%20mood%20disorders%20in%20Japan&rft.jtitle=Psychiatry%20and%20clinical%20neurosciences&rft.au=Uchida,%20Hiroyuki&rft.date=2009-04&rft.volume=63&rft.issue=2&rft.spage=244&rft.epage=246&rft.pages=244-246&rft.issn=1323-1316&rft.eissn=1440-1819&rft_id=info:doi/10.1111/j.1440-1819.2008.01920.x&rft_dat=%3Cproquest_cross%3E20546154%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4520-1ec0dd442174063d63ce10b1fe036f5324647c712ec5fcde852a9d64c38724753%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20546154&rft_id=info:pmid/19175759&rfr_iscdi=true |